NCT02520895 Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia Status COMPLETED Phase N/A
NCT02518958 A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab Status COMPLETED Phase PHASE1
NCT02504190 Non-interventional Study on TEAM Conditioning in Patients With Lymphoma (TEAM) Status COMPLETED Phase N/A
NCT02503423 Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02490891 Study of the Angiogenesis by PET/CT in Patients With Lymphoma Status COMPLETED Phase PHASE2
NCT02477878 Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02465060 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02456350 Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies Status UNKNOWN Phase PHASE1
NCT02436707 Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02423915 Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention Status COMPLETED Phase PHASE1
NCT02423356 Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin Status COMPLETED Phase N/A
NCT02419469 Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Status TERMINATED Phase PHASE2
NCT02414724 Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma Status TERMINATED Phase PHASE1
NCT02409121 A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers Status COMPLETED Phase NA
NCT02408042 Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) Status WITHDRAWN Phase PHASE1/PHASE2
NCT02392039 Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma Status TERMINATED Phase EARLY_PHASE1